Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients
在JC病毒阳性复发缓解型多发性硬化症患者中，奥瑞珠单抗治疗后接受那他珠单抗治疗
期刊:Multiple Sclerosis Journal - Experimental, Translational and Clinical
影响因子:2.3
doi:10.1177/20552173211013831
van Lierop, Zygj; Toorop, A A; Coerver, Eme; Willemse, Eaj; Strijbis, Emm; Kalkers, N F; Moraal, B; Barkhof, F; Teunissen, C E; Killestein, J; van Kempen, Zle
